4dx share price forecast

About the company.

Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. This share price information is delayed by 15 minutes. The overall consensus recommendation for 4DMedical is Buy. You can view the full broker recommendation list by unlocking its StockReport. To buy shares in 4DMedical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. Based on an overall assessment of its quality , value and momentum 4DMedical is currently classified as a Neutral.

4dx share price forecast

March 5, James Mickleboro. The latest member of the All Ordinaries index is getting some love this week. January 22, James Mickleboro. December 22, James Mickleboro. Analysts have put buy ratings on these small caps and see big potential returns. December 5, James Mickleboro. December 1, James Mickleboro. November 29, James Mickleboro. November 20, James Mickleboro. November 13, James Mickleboro.

May 4, Monica O'Shea. Recent future growth updates. No longer forecast to breakeven Feb

The 4Dmedical Ltd stock price is 0. The 4DX stock price can go up from 0. The 4DX "4DX" future stock price will be 1. According to our analysis, this will not happen. Not within a year. See above. For example 1.

Key events shows relevant news articles on days with large price movements. Imugene Ltd. IMU 0. Pro Medicus Limited. PME 1. Dimerix Ltd.

4dx share price forecast

EPS is expected to grow by Return on equity is forecast to be Earnings growth rate. Earnings vs Savings Rate: 4DX is forecast to remain unprofitable over the next 3 years. Earnings vs Market: 4DX is forecast to remain unprofitable over the next 3 years. High Growth Earnings: 4DX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: 4DX's revenue

Digital immersion gallery calgary

July 21, James Mickleboro. Mr John Livingston has lectured in Australia and abroad on the digital radiology environment, as well as business strategies and systems within the commercial sector. If you are good with personal finance and are looking to invest, you will find the 4Dmedical Ltd on AU stock exchange. How do 4DMedical's earnings and revenue compare to its market cap? When will 4DX price fall? Will 4DX price go up? He later worked for Towers Perrin to Brussels and London as an asset consultant before moving to Credit Suisse Asset Management and then Schroders Investment Management as a portfolio manager in their respective multi-manager teams. Issue of options. At Walletinvestor. Feb Guru Screens. Max: 0. Full year earnings: EPS exceeds analyst expectations while revenues lag behind Aug

March 5, James Mickleboro.

First half earnings released Aug Operating Margin. New minor risk - Profitability Sep PEG Ratio f. If you are looking for stocks with good return, 4Dmedical Ltd can be a profitable investment option. View Past Performance. Year To Date Return 1. Full year earnings: EPS exceeds analyst expectations while revenues lag behind Aug PE Ratio Range. Shares Outstanding Financial Health. We can't guarantee any profit. Franking -. Net Income. Revenue is forecast to grow